Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

These gene variations are not linked to alopecia areata in Egyptians.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

The girl's regrown brown hair had less of certain pigments than her original black hair.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.